Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study.

@article{Grande2015AsenapinePP,
  title={Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study.},
  author={Iria Grande and Diego Hidalgo-Mazzei and Evaristo Nieto and M. Sanz A. Llombart A. A. Bayod J. Mur and Cristina Bayona S{\'a}ez and I. L. Garc{\'i}a Forcada and Eduard Vieta},
  journal={European psychiatry : the journal of the Association of European Psychiatrists},
  year={2015},
  volume={30 4},
  pages={528-34}
}
BACKGROUND Asenapine is the most recent compound that has been FDA- and EMA-approved for treatment of mania. Its efficacy and safety have been assessed in placebo-controlled trials, but little is known about its performance in routine clinical conditions. In this study, we compared features of patients treated with adjunctive asenapine or other adjunctive antipsychotics and the costs of the treatment. METHODS A combined prospective and retrospective data collection and analysis was conducted… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS